Compound comparison

NAD+ vs 5-Amino-1MQ

Both appear in NAD+ research, but they approach the same question from opposite directions.

NAD+ is the coenzyme itself — supplying the end product directly. 5-Amino-1MQ is an enzyme inhibitor that blocks NNMT, reducing how much nicotinamide gets methylated and diverted away from the salvage pathway that regenerates NAD+. One adds; the other stops subtraction.

Side by side

	NAD+	5-Amino-1MQ
Molecule class	Dinucleotide coenzyme	Small-molecule quinolinium
Is it a peptide?	No	No
Mechanism	Supplies the coenzyme directly	Inhibits NNMT, preserving nicotinamide for NAD+ salvage
Acts on	Redox reactions, sirtuins, PARP enzymes	The NNMT enzyme
Tissue focus in literature	Broad — energy metabolism, DNA repair	Adipose tissue and liver, where NNMT is highly expressed
Typical vial size	100mg to 1,000mg	50mg

Choosing between them

Researchers work with NAD+ when

the question concerns the coenzyme pool directly — redox state, sirtuin activity, or PARP consumption during DNA repair. Supplying NAD+ is the direct approach.

Researchers work with 5-Amino-1MQ when

the question is about NNMT specifically, or about adipocyte energy metabolism. Its effect on NAD+ is indirect, which makes it a different experimental tool rather than a substitute.

PH Buffered NAD+ 5,000MG Kit

500mg • 10 Vials

$325.00

View product

5-Amino-1MQ 500mg Kit

50mg • 10 Vials

$249.00

View product

Common questions

Is 5-Amino-1MQ a form of NAD+?

No. It is a small-molecule enzyme inhibitor, structurally unrelated to NAD+. It affects NAD+ availability indirectly by inhibiting NNMT, the enzyme that methylates nicotinamide and removes it from the salvage pathway.

Which one raises NAD+ more?

That depends entirely on the model and is not a settled question. They act through different mechanisms — direct supply against reduced precursor loss — and comparative work examines both strategies rather than establishing one as superior.

Are either of these peptides?

Neither. NAD+ is a dinucleotide coenzyme; 5-Amino-1MQ is a quinolinium compound. Both are catalogued alongside peptides because they appear in the same metabolic and longevity research.

This comparison covers structure, receptor targets and development stage — matters of published record. It does not rank the compounds or claim either produces better outcomes. Much of the supporting literature is preclinical. All products are supplied for laboratory research use only.

See the studies behind both compounds →